Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.07M Buy
+54,465
New +$5.13M 0.07% 380
2026
Q1
Sell
-28,180
Closed -$2.68M 3865
2025
Q4
$2.68M Buy
28,180
+13,382
+90% +$1.35M 0.07% 393
2025
Q3
$1.46M Buy
+14,798
New +$1.58M 0.08% 349
2024
Q4
Sell
-3,862
Closed -$459K 2318
2024
Q3
$459K Buy
+3,862
New +$355K 0.03% 878
2024
Q2
Sell
-5,214
Closed -$481K 1896
2024
Q1
$481K Buy
+5,214
New +$500K 0.06% 506
2023
Q3
Sell
-3,362
Closed -$363K 1580
2023
Q2
$363K Sell
3,362
-3,627
-52% -$408K 0.07% 580
2023
Q1
$871K Buy
6,989
+5,233
+298% +$719K 0.18% 70
2022
Q4
$264K Sell
1,756
-8,897
-84% -$1.37M 0.06% 679
2022
Q3
$1.44M Buy
10,653
+8,038
+307% +$1.23M 0.36% 18
2022
Q2
$390K Buy
+2,615
New +$400K 0.16% 183
2022
Q1
Sell
-1,832
Closed -$472K 688
2021
Q4
$472K Buy
+1,832
New +$502K 0.27% 82
2021
Q3
Sell
-1,256
Closed -$281K 708
2021
Q2
$281K Sell
1,256
-2,663
-68% -$502K 0.09% 398
2021
Q1
$428K Buy
+3,919
New +$416K 0.21% 139

Other funds holding BNTX

XTX Topco's BNTX Position: Q2 2026 in Review

XTX Topco opened a new position in BioNTech (BNTX) in Q2 2026: 54,465 shares worth $5.07M. The stake represents 0.07% of the portfolio and ranks #380 among its holdings. This is a return to the name: XTX Topco previously reported a position in BNTX as recently as Q4 2025.

XTX Topco first reported a position in BNTX in Q1 2021 and has held it in 13 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • XTX Topco held 54,465 shares of BioNTech worth $5.07M as of Q2 2026.
  • BioNTech was a new XTX Topco position in Q2 2026.
  • BioNTech made up 0.07% of XTX Topco's portfolio in Q2 2026, its #380 holding.
  • XTX Topco first reported a position in BioNTech in Q1 2021 and has held it in 13 quarters since.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.